ACSL3
Basic information
Region (hg38): 2:222860942-222944639
Previous symbols: [ "FACL3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 17 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 3 | 2 |
Variants in ACSL3
This is a list of pathogenic ClinVar variants found in the ACSL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-222908805-C-T | Benign/Likely benign (Mar 01, 2023) | |||
2-222908851-C-T | not specified | Uncertain significance (Jun 16, 2023) | ||
2-222908870-A-G | not specified | Uncertain significance (Mar 20, 2023) | ||
2-222908890-C-G | not specified | Uncertain significance (Aug 12, 2021) | ||
2-222916424-A-G | not specified | Uncertain significance (Oct 25, 2023) | ||
2-222916427-G-T | not specified | Uncertain significance (Aug 01, 2022) | ||
2-222916430-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
2-222916468-A-G | Benign (May 04, 2018) | |||
2-222919158-A-T | not specified | Uncertain significance (May 01, 2024) | ||
2-222919191-A-G | Likely benign (May 30, 2018) | |||
2-222919199-A-G | not specified | Likely benign (Jun 27, 2023) | ||
2-222921325-T-C | not specified | Uncertain significance (May 26, 2022) | ||
2-222922760-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
2-222922811-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
2-222922829-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
2-222922830-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
2-222923079-C-A | not specified | Uncertain significance (May 30, 2023) | ||
2-222927019-T-C | not specified | Uncertain significance (Jan 04, 2022) | ||
2-222927027-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
2-222927117-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
2-222930750-A-G | not specified | Uncertain significance (Nov 15, 2021) | ||
2-222933168-C-G | not specified | Uncertain significance (Oct 03, 2022) | ||
2-222934531-T-C | not specified | Uncertain significance (Nov 12, 2021) | ||
2-222934572-G-A | Benign (Aug 24, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSL3 | protein_coding | protein_coding | ENST00000357430 | 14 | 83706 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000348 | 1.00 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.01 | 283 | 396 | 0.715 | 0.0000211 | 4711 |
Missense in Polyphen | 97 | 176.49 | 0.5496 | 2050 | ||
Synonymous | -0.960 | 154 | 140 | 1.10 | 0.00000755 | 1377 |
Loss of Function | 3.72 | 13 | 37.6 | 0.346 | 0.00000204 | 468 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000590 | 0.0000590 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL3 mediates hepatic lipogenesis (By similarity). Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates (By similarity). Has mainly an anabolic role in energy metabolism. Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins). {ECO:0000250, ECO:0000269|PubMed:18003621}.;
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);Peroxisome - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Fatty acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Fatty Acid Beta Oxidation;Fatty Acid Biosynthesis;Mitochondrial LC-Fatty Acid Beta-Oxidation;PPAR signaling pathway;Liver steatosis AOP;stearate biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;fatty acid activation;Leukotriene metabolism;Omega-3 fatty acid metabolism;Metabolism;Fatty acid metabolism;γ-linolenate biosynthesis;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Di-unsaturated fatty acid beta-oxidation;Phytanic acid peroxisomal oxidation;fatty acid β-oxidation (peroxisome);icosapentaenoate biosynthesis II (metazoa);fatty acid β-oxidation;Synthesis of very long-chain fatty acyl-CoAs
(Consensus)
Recessive Scores
- pRec
- 0.186
Intolerance Scores
- loftool
- 0.500
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.49
Haploinsufficiency Scores
- pHI
- 0.827
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.512
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acsl3
- Phenotype
- growth/size/body region phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- long-chain fatty acid metabolic process;fatty acid biosynthetic process;brain development;response to nutrient;response to organic cyclic compound;very-low-density lipoprotein particle assembly;long-chain fatty-acyl-CoA biosynthetic process;positive regulation of Golgi to plasma membrane protein transport;long-chain fatty acid import;positive regulation of secretion;positive regulation of phosphatidylcholine biosynthetic process
- Cellular component
- mitochondrial outer membrane;peroxisomal membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;lipid droplet;membrane;integral component of membrane;perinuclear region of cytoplasm
- Molecular function
- long-chain fatty acid-CoA ligase activity;ATP binding;protein kinase binding;protein domain specific binding;decanoate-CoA ligase activity